Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Precigen Inc | PGEN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.30 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.30 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.8354 - 1.8799 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 1.30 | USD |
Precigen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 323.59M | 248.92M | - | 6.23M | -95.9M | -0.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Precigen News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PGEN Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.40 | 1.41 | 1.30 | 1.34 | 547,079 | -0.10 | -7.14% |
| 1 Month | 1.43 | 1.49 | 1.20 | 1.36 | 688,101 | -0.13 | -9.09% |
| 3 Months | 1.66 | 1.785 | 1.20 | 1.42 | 801,214 | -0.36 | -21.69% |
| 6 Months | 1.10 | 1.785 | 1.0836 | 1.38 | 999,555 | 0.20 | 18.18% |
| 1 Year | 1.23 | 1.8799 | 0.8354 | 1.34 | 1,262,854 | 0.07 | 5.69% |
| 3 Years | 6.62 | 8.72 | 0.805 | 2.30 | 1,355,373 | -5.32 | -80.36% |
| 5 Years | 5.13 | 11.10 | 0.805 | 3.43 | 1,383,650 | -3.83 | -74.66% |
Precigen Description
| Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals; Exemplar, and Trans Ova. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs. |
